Axplora

Progress isn’t just about technology—it’s about the bold minds who dare to imagine new possibilities and drive industrial excellence. 🌟 And today, on International Women’s Day, we celebrate the #women who drive progress, break barriers, and redefine what’s possible in pharmaceutical manufacturing. From pioneering complex API solutions to leading strategic partnerships, the women at Axplora are transforming our industry—ensuring life-changing treatments reach patients faster and more efficiently. What does being a woman in pharmaceutical manufacturing mean? 💡 We asked some of the trailblazing women at Axplora to share their insights. Swipe through to hear their voices and celebrate their impact. 🔬 To all the women in science, manufacturing, and healthcare - your leadership, expertise, and vision inspire us all. Today and every day, we celebrate you. ♀️ Virginie ROUSSEAU ♀️ A Monisha ♀️ Félicie DENET ♀️ Florence COLLET - LEIRIS ♀️ #IWD2024 #WomenInSTEM #AxploraSites

The pharma landscape is evolving fast, and API manufacturing is at a turning point. In his latest article, Martin Meeson, CEO of Axplora, unpacks the key trends shaping 2025: 💉 Surging demand for manufacturing complex APIs like #GLP-1 receptor agonists and #ADCs. 🌍 Supply chain resilience is driving a shift to localized production and smarter logistics. 🔬 Sustainability & AI-driven innovation are redefining efficiency in API manufacturing. As a global #CDMO and #API manufacturer, Axplora is leading the way—combining agility, expertise, and future-ready solutions to keep your supply chain ahead of the curve. ✨ Let’s dare to imagine new manufacturing possibilities—together, we can accelerate your next project. 📖 Read the full article & book a #DCATWeek meeting 👉 https://lnkd.in/g5yZShh9 #APIManufacturing #CDMO #DCAT2025 #DCATWeek

Day 1 - what a success! Our team had a great time engaging with existing and prospective clients, discussing unmet outsourcing needs within the #ADC manufacturing space and how we can use our technical expertise and state-of-the-art workshops, including the expansion of our commercial payload production capabilities, to bring their next generation of therapies to market without delay! With over 20 years of experience in ADC manufacturing and a key supplier of 40% of all commercially available ADC's, we're your go-to partner to bring your program to life! Don’t hesitate to stop by Booth #27 while you’re still here for Day 2. We look forward to meeting you! #WorldADC #ADC #Manufacturing

🚀 𝐏𝐫𝐞𝐬𝐬 𝐑𝐞𝐥𝐞𝐚𝐬𝐞 → 𝐀𝐱𝐩𝐥𝐨𝐫𝐚 𝐄𝐱𝐩𝐚𝐧𝐝𝐬 𝐂𝐨𝐦𝐦𝐞𝐫𝐜𝐢𝐚𝐥 𝐏𝐚𝐲𝐥𝐨𝐚𝐝 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐢𝐨𝐧 𝐚𝐭 𝐋𝐞 𝐌𝐚𝐧𝐬! We’re strengthening our position as a key player in the supply chain of 40% of all commercial ADCs with a state-of-the-art payload manufacturing workshop at our Le Mans site. This new GMP facility will support the growing demand for next-gen oncology therapies, offering unparalleled flexibility and efficiency as we push the boundaries of manufacturing innovation. With 20 years clinical and commercial track record and over 250 cGMP batches produced, we're equipped to meet commercial-scale demands and partner with innovative pharmaceutical companies to bring life-saving treatments to patients faster. Explore it 👉 https://lnkd.in/gzhSNF7V #ADC #Payloads #Oncology #WorldADC #PressRelease

Some CDMOs follow. Axplora leads. Any CDMO can manufacture. But real partnership in small molecules and ADCs? That’s different. At Axplora, we don’t believe in one-size-fits-all. We believe in: ✅ A bespoke approach — because no two projects are the same. ✅ Harnessing advanced technologies only where necessary to drive efficiency. ✅ A track record of industrial scale-up - supporting hundreds of customers worldwide. We dare to imagine a better way — and we make it happen. Are you ready to see what’s possible? Let’s connect at DCAT Week. 🔗 https://lnkd.in/g4qKUaTm #PharmaManufacturing #CDMO #DCATWeek #DCAT

👏 Congratulations to the Zymvol Biomodeling team for their newly closed investment round of €3 million. At Axplora we’re happy to see collaborators like Zymvol reach new milestones in their journey to make enzymes available to everyone.

The countdown is on—just one month until #DCATWeek 2025, the premier event for the pharmaceutical industry! ⏰ At this year’s event, we’re not just showcasing manufacturing innovation—we’re redefining the possible: 🔬 Revolutionizing API development and manufacturing. ⚡ Speeding time to market with world-class technologies. 🤝 Empowering partnerships to unlock new frontiers. #NYC streets pulse with energy and stories, while we chart a bold path towards the future. Whether it’s pioneering #ADC technologies (where we produce 40% of commercial ADCs), customizing #API solutions, or over-achieving time-to-market, we are here to navigate the future together. 🚀 This isn’t just an invitation—it’s a call to #challenge the status quo. 🔍 Let’s explore solutions others haven’t dared to imagine. 👉 → Axplora CDMO: https://lnkd.in/g4qKUaTm → Farmabios, member of Axplora & PharmaZell: sales@axplora.com #DCATWeek2025 #CDMO #APIManufacturing

At Axplora, we harness the power of chemistry by unlocking hidden energy to supercharge the safety of our processes and the quality of our APIs. Just as a superhero transforms challenges and hazards into triumphs, we turn energetic chemistry into life-changing solutions for patients worldwide. For this month’s #FAQFriday, our experts are revealing: 🔎 What energetic chemistry is and why it’s essential 🦸♂️ How we ensure superhero-level safety in handling hazardous materials 🛡️ The cutting-edge measures that protect every process and ensure API excellence ⚙️ The powerful tools and processes that make us industry leaders Ready to unlock the secret to Axplora’s superpowers? Download our expert FAQ for an exclusive behind-the-scenes look at the chemistry that powers the extraordinary. 👉 https://lnkd.in/gUFV8vvr #HazardousChemistry #EnergeticChemistry #AxploraSuperpower #APIInnovation

We're proud to announce a €50 million investment in our Mourenx site to further enhance our capabilities in the production of GLP-1 therapies. Our Mourenx facility plays a crucial role in manufacturing high-quality GLP-1s, offering targeted therapies for complex diseases with unprecedented efficacy and tolerability. This initiative, built on strong customer partnerships, reinforces Axplora’s role as a trusted partner in manufacturing life-changing, breakthrough medicines. 📢 Find out more about this exciting development: https://lnkd.in/eKMtacvX #GLP1 #Pharma #CDMO

This International Day of Women and Girls in Science, we’re celebrating the fearless explorers at Axplora who don’t just follow the map—they redraw it, coming up with solutions others dare not imagine. 🗺️🔬 These pioneers don’t wait for solutions—they create them, breaking barriers and disrupting the status quo in pharmaceutical manufacturing. Where others see obstacles, they see opportunities. Where others hesitate, they push forward. At Axplora, we believe diversity fuels discovery, and our scientists are fearless innovators—pushing boundaries and redefining what’s possible. The women driving our breakthroughs stand at the forefront, proving that bold thinking leads to game-changing science. Swipe through to hear from the #women leading the way—sharing their journeys, insights, and advice for the next generation of scientific explorers. 👩🔬🔬✨ Banupriya Chenniappan @Anaïs Paineau Celine Belin   #WomenInScience #WomenInSTEM #PioneeringInnovation #AgileInnovator #DareToImagine